Samuel J. Adams - Pomerantz LLP

Samuel J. Adams became an Associate at Pomerantz in January 2012 and was elevated to Of Counsel to the Firm in 2021. He has been recognized as a Super Lawyers® Rising Star every year from 2015 through 2021. Sam focuses his practice on corporate governance litigation and has served as a member of the litigation team in numerous actions that concluded in successful resolutions for stockholders. He was an integral member of the litigation team that secured a $5.6 million settlement on behalf of a class of shareholders of Physicians Formula Holdings, Inc., following an ignored merger offer. In re Physicians Formula Holdings, Inc. S’holder Litig., C.A. No. 7794-VCL (Del. Ch. Ct.).

Sam was also instrumental in achieving a settlement in Strougo v. Hollander, C.A. No. 9770-CB (Del. Ch. Ct.), which provided for a 25% price increase for members of the class cashed out in the going-private transaction and established that fee-shifting bylaws adopted after a challenged transaction do not apply to stockholders affected by the transaction. Additionally, he was on the team of Pomerantz attorneys who obtained the elimination of stand-still provisions that allowed third parties to bid for Great Wolf Resorts, Inc., resulting in the emergence of a third-party bidder and approximately $94 million (57%) in additional merger consideration for Great Wolf shareholders. In re Great Wolf Resorts, Inc. S’holder Litig., C.A. No. 7328-VCN (Del. Ch.).

Sam is a 2009 graduate of the University of Louisville Louis D. Brandeis School of Law. While in law school, he was a member of the National Health Law Moot Court Team. He also participated in the Louis D. Brandeis American Inn of Court.

Sam is admitted to practice in New York, the United States District Courts for the Southern, Northern, and Eastern Districts of New York and the Eastern District of Wisconsin, and the United States Court of Appeals for the Fifth Circuit.